NCT00308178: Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer |
|
|
| Completed | N/A | 66 | US | Abraxane | Harold J. Burstein, MD, PhD, Celgene Corporation, Beth Israel Deaconess Medical Center, Massachusetts General Hospital | Breast Cancer | 09/06 | 06/08 | | |
TRIBECA, NCT02064829: Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer |
|
|
| Completed | N/A | 111 | US, Europe, RoW | Nab-paclitaxel, Paclitaxel albumin-bound particles for injectable suspension, IG-001, Paclitaxel polymeric micelles for injectable suspension, Genexol-PM, Cynviloq | Sorrento Therapeutics, Inc. | Metastatic Breast Cancer, Locally Recurrent Breast Cancer | 02/15 | 07/15 | | |